Log In
Print
BCIQ
Print
Print this Print this
 

AT-B100, JR-051

  Manage Alerts
Collapse Summary General Information
Company JCR Pharmaceuticals Co. Ltd.
DescriptionRecombinant human alpha galactosidase A enzyme
Molecular Target Alpha galactosidase A
Mechanism of ActionEnzyme replacement therapy
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPreclinical
Standard IndicationFabry's disease
Indication DetailsTreat Fabry's disease
Regulatory Designation

Partner

Amicus Therapeutics Inc.; GlaxoSmithKline plc


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today